- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.07. | The Considered appoints Tina Bertolini as chief client services officer | ||
| 07.07. | Alzheimer's disease - the silent pandemic and the positive impact of AI | ||
| 04.07. | Communiqué 2025: celebrating excellence in healthcare communications | ||
| 04.07. | UK government publishes 10 Year Health Plan for England to 'reinvent' NHS | ||
| 04.07. | Beyond the badge: communicating the business case for DEI | ||
| 03.07. | AbbVie to expand immunology capabilities with $2.1bn Capstan acquisition | ||
| 03.07. | Avalere Health appoints Saiqa Khan as head of growth | ||
| 03.07. | ASCO 2025 - bringing a sense of urgency to the war against cancer | ||
| 02.07. | CHMP recommends tablet formulation of BeOne's targeted cancer drug Brukinsa | ||
| 02.07. | The Considered appoints Rob Fuller as chief strategy officer | ||
| 02.07. | Traitorous doubts | ||
| 01.07. | UCB shares promising results for fenfluramine in ultra-rare form of epilepsy | ||
| 01.07. | Avalere Health appoints Jocelyn Crouch as head of brand strategy | ||
| 01.07. | Why tariffs could fuel a new era of domestic pharma manufacturing | ||
| 30.06. | FDA approves Sobi's Gamifant to treat severe inflammatory arthritis complication | ||
| 30.06. | Inizio Evoke appoints Kelly Cusumano as executive vice president, growth and client innovation | ||
| 30.06. | DCODE: your gateway to accelerating local innovation adoption in the UK | ||
| 27.06. | Novartis and ProFound enter cardiovascular disease collaboration worth $750m per target | ||
| 27.06. | Sanofi's Sarclisa recommended by CHMP for new multiple myeloma indication | ||
| 27.06. | Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi | ||
| 27.06. | Winning commercial's AI race with connected CRM and data | ||
| 26.06. | Gilead Sciences and Kymera enter oncology partnership worth up to $750m | ||
| 26.06. | MHRA approves Accord Healthcare's Hetronifly to treat aggressive form of lung cancer | ||
| 26.06. | Ipsen receives CHMP recommendation for Cabometyx in neuroendocrine tumours | ||
| 26.06. | The Considered appoints Emily Knight-Kristoffersen as chief creative officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .